Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.2 (
NQO1
)
6,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oxidative damages have adverse effects on mammals. Growing studies have focused on exploring new antioxidants. Here, we report that
Lactobacillus frumenti
increases the total antioxidation capacity activities and decreases the total reactive oxygen species levels in porcine intestinal epithelial cells. Comparative proteomics revealed that expressions of peroxiredoxin 2, isocitrate dehydrogenase 1,
NAD(P)H dehydrogenase
quinone 1, antioxidant protein 1, and metallothionein-2A, which are associated with antioxidant defense system, were significantly increased with
L. frumenti
treatment. In germ-free mice,
L. frumenti
treatment also remarkably improves the intestinal antioxidant capacity. We further illustrated that nitric oxide production-mediated by
nitric oxide synthase 1
activation is essential for
L. frumenti
-induced improvements in intestinal epithelial antioxidant capacity and barrier function. This study suggested that
L. frumenti
may be a potential probiotic used to prevent oxidative stress-induced aging and diseases in mammals.-Nie, Y., Hu, J., Hou, Q., Zheng, W., Zhang, X., Yang, T., Ma, L., Yan, X.
Lactobacillus frumenti
improves antioxidant capacity
via
nitric oxide synthase 1
in intestinal epithelial cells.
...
PMID:
Lactobacillus frumenti
improves antioxidant capacity
via
nitric oxide synthase 1 in intestinal epithelial cells. 3126 91